首页> 外文期刊>BMC Pulmonary Medicine >Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: A prospective, cohort study
【24h】

Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: A prospective, cohort study

机译:住院的人类免疫缺陷病毒感染患者的分枝杆菌和非细菌性肺部并发症:一项前瞻性队列研究

获取原文
           

摘要

Background A prospective observational study was done to describe nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus (HIV) infection. Methods The study included 1,225 consecutive hospital admissions of 599 HIV-infected patients treated from April 1995 through March 1998. Data included demographics, risk factors for HIV infection, Acute Physiology and Chronic Health Evaluation (APACHE) II score, pulmonary complications, CD4+ lymphocyte count, hospital stay and case-fatality rate. Results Patient age (mean ± SD) was 38.2 ± 8.9 years, 62% were men, and 84% were African American. The median APACHE II score was 14, and median CD4+ lymphocyte count was 60/μL. Pulmonary complications were Pneumocystis carinii pneumonia (85) in 78 patients, Mycobacterium avium complex (51) in 38, Mycobacterium tuberculosis (40) in 35, Mycobacterium gordonae (11) in 11, Mycobacterium kansasii (10) in 9, Cytomegalovirus (10) in 10, Nocardia asteroides (3) in 3, fungus ball (2) in 2, respiratory syncytial virus (1), herpes simplex virus (1), Histoplasma capsulatum (1), lymphoma (3) in 3, bronchogenic carcinoma (2) in 2, and Kaposi sarcoma (1). The case-fatality rate of patients was 11% with Pneumocystis carinii pneumonia; 5%, Mycobacterium tuberculosis; 6%, Mycobacterium avium complex; and 7%, noninfectious pulmonary complications. Conclusion Most pulmonary complications in hospitalized patients with HIV are from Pneumocystis and mycobacterial infection.
机译:背景技术进行了一项前瞻性观察性研究,以描述住院的人类免疫缺陷病毒(HIV)感染患者的非细菌性肺部并发症。方法该研究包括1995年4月至1998年3月接受治疗的599例HIV感染患者的1,225例连续入院。数据包括人口统计学,HIV感染的危险因素,急性生理和慢性健康评估(APACHE)II评分,肺部并发症,CD4 + 淋巴细胞计数,住院时间和病死率。结果患者年龄(平均±SD)为38.2±8.9岁,男性为62%,非裔美国人为84%。 APACHE II评分中位数为14,CD4 + 淋巴细胞计数中位数为60 /μL。肺部并发症为卡氏肺孢子虫肺炎(85)(78例),鸟分枝杆菌复合体(51)(38),结核分枝杆菌(40)(35),戈登分枝杆菌(11)(11),堪萨斯分枝杆菌(10)(9),巨细胞病毒(10)。 10,诺卡氏小行星(3),3,真菌球(2),2,呼吸道合胞病毒(1),单纯疱疹病毒(1),荚膜组织胞浆(1),淋巴瘤(3),3,支气管癌(2) ),2)和卡波西肉瘤(1)。卡氏肺孢子虫肺炎患者的病死率为11%。 5%,结核分枝杆菌; 6%,鸟分枝杆菌复合物;以及7%的非感染性肺部并发症。结论住院HIV感染者肺部并发症多来自于肺气肿和分枝杆菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号